Last updated: February 15, 2021
Sponsor: Medstar Health Research Institute
Overall Status: Trial Not Available
Phase
N/A
Condition
Female Hormonal Deficiencies/abnormalities
Hormone Deficiencies
Thyroid Disorders
Treatment
N/AClinical Study ID
NCT01707056
2011-338
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients with thyroid carcinoma after standard care of treatment on stable dose ofSynthroid with a detectable baseline TSH
Exclusion
Exclusion Criteria:
- Pregnancy
- Undetectable baseline TSH
- Not willing to drink coffee, coffee with milk, or black tea
- Age less than 18 or greater than 60 years old
- Taking generic thyroid hormone (levothyroxine) and not brand-name Synthroid
- Dose of thyroid medication has been recently changed (less than 3 months ago)
- Currently receiving treatment for gastroesophageal reflux disease, gastritis, stomachor intestinal cancer, inflammatory bowel disease, or H. pylori
- Taking cholestyramine resin, colestipol hydrochloride, sucralfate, iron sulphate,aluminum containing antacids, activated charcoal, raloxifene, and herbal remedies
- History of previous gastric or small intestine surgery
- Diagnosis of kidney or liver disease, congestive heart failure, anemia, biliarydisease, pancreatitis
Study Design
Study Start date:
September 01, 2012
Estimated Completion Date:
June 30, 2016
Study Description
Connect with a study center
Georgetown University Hospital
Washington, District of Columbia 20007
United StatesSite Not Available
Washington Hospital Center
Washington, District of Columbia 20010
United StatesSite Not Available
MedStar St. Mary's Hospital
Leonardtown, Maryland 20650
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.